Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1988 Aug;60(2):162–164. doi: 10.1136/hrt.60.2.162

Pericardiocentesis and systemic cytotoxic chemotherapy in the management of cardiac tamponade secondary to disseminated breast carcinoma.

S Ramakrishnan 1, A J Marshall 1, J G Pickard 1, C J Tyrrell 1
PMCID: PMC1216540  PMID: 3415876

Abstract

Three patients with cardiac tamponade secondary to disseminated breast carcinoma were treated by pericardiocentesis followed by systemic cytotoxic chemotherapy. This approach controlled pericardial effusion in all the patients and extended their survival.

Full text

PDF
162

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bitran J. D., Evans R., Brown C. The management of cardiac tamponade in patients with breast cancer. J Surg Oncol. 1984 Sep;27(1):42–44. doi: 10.1002/jso.2930270110. [DOI] [PubMed] [Google Scholar]
  2. Cham W. C., Freiman A. H., Carstens P. H., Chu F. C. Radiation therapy of cardiac and pericardial metastases. Radiology. 1975 Mar;114(3):701–704. doi: 10.1148/114.3.701. [DOI] [PubMed] [Google Scholar]
  3. Haskell R. J., French W. J. Cardiac tamponade as the initial presentation of malignancy. Chest. 1985 Jul;88(1):70–73. doi: 10.1378/chest.88.1.70. [DOI] [PubMed] [Google Scholar]
  4. Hill G. J., 2nd, Cohen B. I. Pleural pericardial window for palliation of cardiac tamponade due to cancer. Cancer. 1970 Jul;26(1):81–93. doi: 10.1002/1097-0142(197007)26:1<81::aid-cncr2820260110>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  5. Horgan J. H. Cardiac tamponade. Br Med J (Clin Res Ed) 1987 Sep 5;295(6598):563–564. doi: 10.1136/bmj.295.6598.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jensen D. M., McFarlane I. G., Portmann B. S., Eddleston A. L., Williams R. Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med. 1978 Jul 6;299(1):1–7. doi: 10.1056/NEJM197807062990101. [DOI] [PubMed] [Google Scholar]
  7. Maher E. R., Buckman R. Intrapericardial installation of bleomycin in malignant pericardial effusion. Am Heart J. 1986 Mar;111(3):613–614. doi: 10.1016/0002-8703(86)90080-3. [DOI] [PubMed] [Google Scholar]
  8. Piehler J. M., Pluth J. R., Schaff H. V., Danielson G. K., Orszulak T. A., Puga F. J. Surgical management of effusive pericardial disease. Influence of extent of pericardial resection on clinical course. J Thorac Cardiovasc Surg. 1985 Oct;90(4):506–516. [PubMed] [Google Scholar]
  9. Press O. W., Livingston R. Management of malignant pericardial effusion and tamponade. JAMA. 1987 Feb 27;257(8):1088–1092. [PubMed] [Google Scholar]
  10. Reynolds P. M., Byrne M. J. The treatment of malignant pericardial effusion in carcinoma of the breast. Aust N Z J Med. 1977 Apr;7(2):169–171. doi: 10.1111/j.1445-5994.1977.tb04688.x. [DOI] [PubMed] [Google Scholar]
  11. Smith F. E., Lane M., Hudgins P. T. Conservative management of malignant pericardial effusion. Cancer. 1974 Jan;33(1):47–57. doi: 10.1002/1097-0142(197401)33:1<47::aid-cncr2820330110>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES